Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
This review summarizes the literature evidence on humoral disturbances in arterial hypertension (AH), as well as on AH interrelationship with individual components of metabolic syndrome (MS). Based on the results of multi-centre randomised trials, the rationale for the use of antihypertensive agents...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2011-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1905 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850028094596841472 |
|---|---|
| author | L. I. Abasova R. L. Dashdamirov A. B. Bakhshaliev |
| author_facet | L. I. Abasova R. L. Dashdamirov A. B. Bakhshaliev |
| author_sort | L. I. Abasova |
| collection | DOAJ |
| description | This review summarizes the literature evidence on humoral disturbances in arterial hypertension (AH), as well as on AH interrelationship with individual components of metabolic syndrome (MS). Based on the results of multi-centre randomised trials, the rationale for the use of antihypertensive agents with favourable metabolic profile is demonstrated, in particular, for antagonists of slow calcium channels, angiotensin-converting enzyme inhibitors, and selective imidazoline receptor agonists. |
| format | Article |
| id | doaj-art-a1c3882ecd744cb69003d9638bed118a |
| institution | DOAJ |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2011-08-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-a1c3882ecd744cb69003d9638bed118a2025-08-20T02:59:56Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252011-08-0110410710910.15829/1728-8800-2011-4-107-1091620Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapyL. I. Abasova0R. L. Dashdamirov1A. B. Bakhshaliev2Research Institute of CardiologyResearch Institute of CardiologyResearch Institute of CardiologyThis review summarizes the literature evidence on humoral disturbances in arterial hypertension (AH), as well as on AH interrelationship with individual components of metabolic syndrome (MS). Based on the results of multi-centre randomised trials, the rationale for the use of antihypertensive agents with favourable metabolic profile is demonstrated, in particular, for antagonists of slow calcium channels, angiotensin-converting enzyme inhibitors, and selective imidazoline receptor agonists.https://cardiovascular.elpub.ru/jour/article/view/1905arterial hypertensionmetabolic syndromeantihypertensive therapy |
| spellingShingle | L. I. Abasova R. L. Dashdamirov A. B. Bakhshaliev Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy Кардиоваскулярная терапия и профилактика arterial hypertension metabolic syndrome antihypertensive therapy |
| title | Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy |
| title_full | Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy |
| title_fullStr | Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy |
| title_full_unstemmed | Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy |
| title_short | Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy |
| title_sort | arterial hypertension and metabolic syndrome specifics of antihypertensive therapy |
| topic | arterial hypertension metabolic syndrome antihypertensive therapy |
| url | https://cardiovascular.elpub.ru/jour/article/view/1905 |
| work_keys_str_mv | AT liabasova arterialhypertensionandmetabolicsyndromespecificsofantihypertensivetherapy AT rldashdamirov arterialhypertensionandmetabolicsyndromespecificsofantihypertensivetherapy AT abbakhshaliev arterialhypertensionandmetabolicsyndromespecificsofantihypertensivetherapy |